Parkinson Disease Dementia: Clinical Trials

24 trials for Parkinson Disease Dementia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 5 recruiting, 4 unknown, 3 terminated. 11 Not applicable, 3 Phase 2, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 5, Active not recruiting 2, Terminated 2, Unknown 1, Withdrawn 1
Phase 23Completed 1, Recruiting 1, Terminated 1
Phase 42Completed 1, Recruiting 1
Phase 11Recruiting 1

Follow Parkinson Disease Dementia: new trials by email Literature Review of Parkinson Disease Dementia trials Research Report on Parkinson Disease Dementia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Visual Hallucinations in Lewy Body Diseases
Behavioral Tasks, MRI/MEG Scans - Lewy Body Disease, Lewy Body Dementia
RecruitingNYU Langone Health2342026-09-152026-09-30
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Diagnostic Test: 18F-FPyCO/SMBT-1 - Parkinson Disease, Parkinson Disease Dementia
RecruitingTianjin Medical University2002026-06-252026-09-08
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims - Dementia With Lewy Bodies, Parkinson Disease Dementia
Phase 4RecruitingVirginia Commonwealth University1202025-12-082026-03-06
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Tributyrin, Placebo - Parkinson Disease, Parkinson Disease Dementia
Phase 1 / Phase 2RecruitingPrabesh Kanel452025-11-072025-11-12
To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease
Implant device - Parkinson Disease Dementia
Not applicableUnknownJiangsu CED Medtech Co., Ltd32024-07-012024-07-10
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Peer Mentor Support and Caregiver Education, Caregiver Education - Lewy Body Dementia, Parkinson Disease Dementia
Not applicableActive not recruitingRush University Medical Center6222024-05-132026-03-20
SHARPEN - Parkinson's Disease Dementia
Non-invasive brainstem stimulation - Parkinson Disease Dementia
Not applicableTerminatedScion NeuroStim92024-05-082025-05-09
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Dementia, Dysphagia
CompletedUniversity of Oregon2192023-11-072025-12-18
Environmental and Reproductive Health Risk for Lewy Body Dementia
Survey - Lewy Body Dementia, Parkinson Disease Dementia
UnknownUniversity of California, San Diego2252023-08-012024-07-03
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate - Parkinson Disease, Lewy Body Dementia
Not applicableTerminatedUniversity of Michigan162023-03-092025-02-12
A Study of Caregiver Connections Via Technology in Dementia
Algorithm, Random Match - Caregiver Stress, Dementia
Not applicableCompletedMayo Clinic4202023-02-062026-10-19
Comparison Between Parkinson's Disease and Parkinson's Dementia Complex (Genetically,Clinical and Electrophysiological)
Cortical excitability using transcranial magnetic stimulation - Parkinson Disease Dementia, Parkinson Disease
UnknownAssiut University402022-11-012023-03-08
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
Algorithm, Random Match - Caregiver Stress, Dementia
Not applicableWithdrawnMayo Clinic2022-09-012022-11-17
Community Outreach for Palliative Engagement -- Parkinson Disease
Parkinson Disease Standard Care, Online Community-Supported Palliative Care - Parkinson Disease Dementia, Parkinson Disease
Not applicableActive not recruitingUniversity of Rochester6322022-04-262026-03-06
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)
ATH-1017, Placebo - Parkinson Disease Dementia, Dementia With Lewy Bodies
Phase 2TerminatedLeonaBio282022-01-202025-03-04
Sing for Your Saunter - Dementia Supplement
Mentally Singing, Listening to music - Parkinson Disease, Parkinson Disease Dementia
Not applicableCompletedWashington University School of Medicine172021-04-192025-01-09
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
No intervention, Probiotic supplement - Dementia Alzheimers, Dementia With Lewy Bodies
UnknownUniversity Rovira i Virgili2402021-04-162023-07-13
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment
Vespa software - Neurodegenerative Diseases, Cognitive Decline
Not applicableCompletedIRCCS Centro Neurolesi Bonino Pulejo602021-03-012024-03-08
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Peer mentor support and caregiver intervention, Focus group to provide feedback on educational materials and mentoring program - Lewy Body Disease, Parkinson Disease Dementia
Not applicableCompletedRush University Medical Center872020-11-022023-01-25
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001
ANAVEX2-73 - Parkinson Disease Dementia
Phase 2CompletedAnavex Life Sciences Corp.1322019-10-102022-08-01

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Lewy Body Disease (13)  ·  Parkinson Disease (10)  ·  Alzheimer Disease (6)  ·  Dementia (5)  ·  Cognitive Dysfunction (4)  ·  Caregiver Burden (2)  ·  Dementia, Vascular (2)  ·  Frontotemporal Dementia (2)  ·  Parkinsonian Disorders (2)  ·  Pick Disease of the Brain (2)  ·  Corticobasal Degeneration (1)  ·  Deafness, Autosomal Recessive 39 (1)  ·  Deglutition Disorders (1)  ·  Hallucinations (1)  ·  Ketosis (1)

Broader conditions

Brain Diseases (20)  ·  Central Nervous System Diseases (20)  ·  Nervous System Diseases (20)  ·  Basal Ganglia Diseases (19)  ·  Movement Disorders (19)  ·  Neurodegenerative Diseases (19)  ·  Synucleinopathies (19)  ·  Parkinsonian Disorders (17)  ·  Mental Disorders (15)  ·  Neurocognitive Disorders (15)  ·  Dementia (9)  ·  Tauopathies (7)  ·  Cognition Disorders (4)  ·  Frontotemporal Lobar Degeneration (4)  ·  Metabolic Diseases (3)

Interventions

Algorithms (2)  ·  Amyloid beta-Protein Precursor (1)  ·  Drug Implants (1)  ·  Neuropsychological Tests (1)  ·  Surveys and Questionnaires (1)  ·  tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (1)  ·  tributyrin (1)

Sponsors

Mayo Clinic (2)  ·  Rush University Medical Center (2)  ·  Anavex Life Sciences Corp. (1)  ·  Assiut University (1)  ·  IRCCS Centro Neurolesi Bonino Pulejo (1)  ·  Jiangsu CED Medtech Co., Ltd (1)  ·  LeonaBio (1)  ·  NYU Langone Health (1)  ·  Prabesh Kanel (1)  ·  Scion NeuroStim (1)  ·  Tianjin Medical University (1)  ·  University Hospital, Strasbourg, France (1)  ·  University Rovira i Virgili (1)  ·  University of California, San Diego (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (16)  ·  Spain (2)  ·  Australia (1)  ·  China (1)  ·  Egypt (1)  ·  France (1)  ·  Italy (1)

Top investigators

Jori E Fleisher, MD MSCE (2)  ·  Julie Fields, PhD, LP (2)  ·  Benzi Kluger, MD (1)  ·  Biyu He, PhD (1)  ·  Ece Bayram, MD, PhD (1)  ·  Francesco Corallo, PSY (1)  ·  Gammon Earhart (1)  ·  Karen Fredriksen-Goldsen, PhD (1)  ·  Kevin Kramer, PhD (1)  ·  Margarita Torrente, Dr (1)  ·  Matthew Barrett (1)  ·  Nicolaas Bohnen, MD (1)  ·  Prabesh Kanel, PhD (1)  ·  Rainer von Coelln, Dr. med. (1)

Results publications

PMID 37385161, PMID 41387197, PMID 42778090

NIH funding

R44AG065088 (2), P30AG028747 (1), P30AG064200 (1), R01AG055488 (1), R01AG079128 (1), R01NS142622 (1), R01NS148898 (1), R43NS132653 (1)